From: Enhanced oral delivery of insulin via the colon-targeted nanocomposite system of organoclay/glycol chitosan/Eudragit®S100
Formulation
Size (nm)
PDI
Zeta-potential (mV)
EE (%)
AC-Ins
192 ± 8.20
0.20 ± 0.01
− 14.0 ± 4.41
97.6 ± 1.20
GAC-Ins
319 ± 9.42
0.46 ± 0.02
15.6 ± 2.31
90.7 ± 3.14
EGAC-Ins
412 ± 10.4
0.32 ± 0.02
− 20.6 ± 0.76
90.3 ± 1.06